Cargando…
ASP-Enzymosomes with Saccharomyces cerevisiae Asparaginase II Expressed in Pichia pastoris: Formulation Design and In Vitro Studies of a Potential Antileukemic Drug
The bacterial enzyme asparaginase is the main treatment option for acute lymphoblastic leukemia. However, it causes side effects, such as immunological reactions, and presents undesirable glutaminase activity. As an alternative, we have been studying asparaginase II from Saccharomyces cerevisiae, co...
Autores principales: | Girão, Luciana F. C., Carvalheiro, Manuela Colla, Ferreira-Silva, Margarida, da Rocha, Surza L. G., Perales, Jonas, Martins, M. Bárbara F., Ferrara, Maria Antonieta, Bon, Elba P. S., Corvo, M. Luísa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536964/ https://www.ncbi.nlm.nih.gov/pubmed/34681778 http://dx.doi.org/10.3390/ijms222011120 |
Ejemplares similares
-
Purification and characterization of asparaginase II from Saccharomyces cerevisiae cloned in Pichia pastoris: a study on a possible antileukemic drug
por: Castro Girão, Luciana Facchinetti de, et al.
Publicado: (2014) -
Heterologous expression of the antimyotoxic protein DM64 in Pichia pastoris
por: Vieira, Saulo Martins, et al.
Publicado: (2017) -
Fed-Batch Production of Saccharomyces cerevisiae L-Asparaginase II by Recombinant Pichia pastoris MUT(s) Strain
por: Rodrigues, David, et al.
Publicado: (2019) -
Optimization and characterization of antileukemic l-asparaginase produced by Fusarium solani endophyte
por: Osama, Sarah, et al.
Publicado: (2023) -
Development of quantitative metabolomics for Pichia pastoris
por: Carnicer, Marc, et al.
Publicado: (2011)